ChemicalBook
hubei PharmaStandard Co., Ltd. 企業の連絡先情報
名前:
hubei PharmaStandard Co., Ltd.
電話番号:
027-19050701
電子メール:
cbbspring@163.com
国籍:
China
ウェブサイト:
www.hbpharmastandard.com
商品の合計数:
371
1
2
3
4
製品カタログ
β-NETA intermediate
β-(ジメチルアミノ)-2′-プロピオナフトン
2752-87-6
C15H17NO
β-NETA
トリメチル[3-(ナフタレン-2-イル)-3-オキソプロピル]アザニウム
31059-54-8
C16H20NO.I
RO5263397
(4S)-4-(3-フルオロ-2-メチルフェニル)-2-オキサゾリン-2-アミン
1357266-05-7
C10H11FN2O
Milrinone impurity Z10
2153433-47-5
C14H15N3O2
Milrinone impurity Z06
80442-07-5
C14H14N2O3
Milrinone impurity Z12
1-ピリジン-2-イルアセトン
6302-02-9
C8H9NO
Milrinone impurity Z11
1-(ピリジン-3-イル)プロパン-2-オン
6302-03-0
C8H9NO
Milrinone impurity Z09
156033-07-7
C12H9N3O2
RO5166017
1048346-74-2
C12H17N3O
Tolterodine impurity Z10
848768-06-9
C29H37NO
Tolterodine impurity Z14
1380491-70-2
C26H37NO3
Tolterodine impurity Z12
2-(3-ヒドロキシ-1-フェニルプロピル)-4-メチルフェノール
851789-43-0
C16H18O2
Tolterodine impurity Z11
209747-04-6
C16H16O2
Pantothenicacid calciumsalt impurity D
50692-78-9
C10H19NO5
Pantothenicacid calciumsalt impurity E
897045-90-8
C12H22N2O6
Tolterodine impurity Z25
3-(2-メトキシ-5-メチルフェニル)-3-フェニルプロピオン酸
109089-77-2
C17H18O3
Tolterodine impurity Z17; 2-(3-amino-1-phenylpropyl)-4-methylphenol hydrochloride
Pantothenicacid calciumsalt impurity G
N-(β-アラニル)-β-アラニン
2140-53-6
C6H12N2O3
Pantothenicacid calciumsalt impurity H; 3-(5-(1-hydroxy-2-methylpropan-2-yl)-4-oxooxazolidin-3-yl)propanoic acid
Pantothenicacid calciumsalt impurity C
D-(-)-パントラクトン
599-04-2
C6H10O3
Pantothenicacid calciumsalt impurity Z04; ethyl (R)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate
Pantothenicacid calciumsalt impurity B
Tolterodine impurity Z08
854306-72-2
C35H41NO2
Tolterodine impurity D; N-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine hydrochloride
1391053-65-8
C20H27NO
Tolterodine impurity Z09
6-メチル-4-フェニル-2-クロマノン
40546-94-9
C16H14O2
Tolterodine impurity A
3-(2-メトキシ-5-メチルフェニル)-3-フェニル プロパノル
124937-73-1
C17H20O2
Tolterodine impurity Z07
380636-49-7
C23H33NO4
Tolterodine impurity G
1554029-91-2
C22H32NO2+
Milrinone impurity Z07
106637-42-7
C12H9N3O
Milrinone impurity Z05
80047-38-7
C12H10N2O3
Pantothenicacid calciumsalt impurity Z05
N-(2-カルボキシエチル)-β-アラニン
505-47-5
C6H11NO4
Milrinone impurity Z02
717818-05-8
C7H6N4O2
2936672-09-0
formoterol impurity E
1616967-26-0
C20H26N2O4
formoterol impurity A
150513-24-9
C18H24N2O3
formoterol impurity H
1337876-26-2
C26H30N2O4
formoterol impurity F
1795129-59-7
C37H46N4O6
formoterol impurity C
1795135-61-3
C20H26N2O4
Norfloxacin impurity D
75001-82-0
C15H18FN3O
Norfloxacin impurity Z13; 9-chloro-6-ethyl-8-fluoro-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate
Norfloxacin impurity G
70459-04-0
C17H18FN3O4
Norfloxacin impurity H
105440-01-5
C19H22FN3O5
Norfloxacin impurity C
177554-64-2
C20H27N5O3
formoterol impurity I
(S,R)-ホルモテロール
67346-50-3
C19H24N2O4
Norfloxacin impurity Z04
1-エチル-4-オキソ-6-フルオロ-7-アミノ-1,4-ジヒドロキノリン-3-カルボン酸
75001-63-7
C12H11FN2O3
formoterol impurity D
1795133-96-8
C20H26N2O4
formoterol impurity G
4-メトキシ-α-メチルベンゼンエタンアミン・塩酸塩
3706-26-1
formoterol impurity B
1224588-66-2
C18H22N2O4
Norfloxacin impurity J; 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Norfloxacin impurity B
75001-77-3
C14H16FN3O3
Rivaroxaban impurity05
Norfloxacin impurity A
7-クロロ-1-エチル-6-フルオロ-1,4-ジヒドロ-4-オキソキノリン-3-カルボン酸
68077-26-9
C12H9ClFNO3
Rivaroxaban impurityK
1365267-36-2
C36H36N6O10
Rivaroxaban impurity02
1879933-39-7
C28H34N6O8
Rivaroxaban impurityJ
1632463-24-1
C38H36Cl2N6O10S2
Rivaroxaban impurity03
1365267-37-3
C22H21N3O7
Rivaroxaban impurity04
1411775-06-8
C14H17N3O4
Krass intermediate 01
2936672-10-3
Tolterodine impurity C
1161940-88-0
C22H31NO
Rivaroxaban impurity01;
C24H19Cl2N3O6S2
Rivaroxaban impurityG
4-[4-[(5S)-5-フタルイミドメチル-2-オキソ-3-オキサゾリジニル]フェニル]-3-モルホリノン
446292-08-6
C22H19N3O6
Rivaroxaban impurityA
865479-71-6
C19H18ClN3O5S
Rivaroxaban impurityH
1770812-37-7
C19H17Cl2N3O5S
Rivaroxaban impurityD
1365267-35-1
C29H32N6O9
Rivaroxaban impurityB
1429334-00-8
C16H19N3O5
Rivaroxaban impurityF
5-クロロ-2-チオフェンカルボン酸
24065-33-6
C5H3ClO2S
Rivaroxaban impurityE
1415566-28-7
C19H19N3O5S
Sitagliptin impurity A
823817-55-6
C16H15F6N5O
Sitagliptin impurity FP-C
1803026-58-5
C16H12F6N4O
Sitagliptin impurity C
945261-48-3
C16H16F5N5O
Sitagliptin impurity B
486460-31-5
C16H16F5N5O
Sitagliptin impurity FP-A
2088771-60-0
C20H19F6N5O5
Sitagliptin impurity FP-D
1253056-18-6
C16H12F6N4O
Sitagliptin impurity FP-B
2805078-75-3
C16H13F6N5O2
Topiroxostat impurity 01
2044704-74-5
C13H7N5O
Topiroxostat impurity 05
31599-25-4
C12H10N6
Topiroxostat impurity 06
2044702-36-3
C13H9N5O2
Sitagliptin impurity FP-E
936630-57-8
C10H10F3NO2
Topiroxostat impurity 03
2044706-78-5
C20H12N10
Topiroxostat impurity 09
1841081-71-7
C13H10N6O
Topiroxostat impurity 07
1992028-94-0
C13H10N6O
Topiroxostat impurity 04; 4,4'-(5,5'-(pyridine-2,4-diyl)bis(4H-1,2,4-triazole-5,3-diyl))dipyridine
Topiroxostat impurity 02
38634-05-8
C12H10N6
Tolterodine impurity E
RAC デスイソプロピルトルテロジン
480432-14-2
C19H25NO
Topiroxostat impurity 25; 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinohydrazide
Topiroxostat impurity 23
21379-40-8
C7H9N5O2
Topiroxostat impurity 24; methyl 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinate
Topiroxostat impurity 28; (Z)-isonicotinohydrazonamide
Topiroxostat impurity 10
577778-82-6
C13H8N6O
Topiroxostat impurity 20
2-シアノイソニコチン酸
161233-97-2
C7H4N2O2
Topiroxostat impurity 22
2050015-91-1
C7H6N4O
Topiroxostat impurity 18
135048-32-7
C7H6N4O
Topiroxostat impurity 13
2044706-50-3
C13H12N8
Topiroxostat impurity 19
2044706-68-3
C13H8N6
Topiroxostat impurity 16
4329-78-6
C12H9N5
Topiroxostat impurity 12; 2-cyano-4-(3-(1-oxidopyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine 1-oxide
Topiroxostat impurity 17
36770-53-3
C12H9N5O
Topiroxostat impurity 14
6975-73-1
C6H7N3O2
Topiroxostat impurity 21; 2-cyanoisonicotinamide
98273-47-3
C7H5N3O
Topiroxostat impurity 11
2044708-04-3
C7H10N6O
1
2
3
4
Copyright 2017 © ChemicalBook. All rights reserved